Prescient Therapeutics Limited (AU:PTX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Prescient Therapeutics Limited has reported a change in Director Allen James Ebens Jr.’s interests, with the expiry of 415,000 unlisted options. Ebens now holds 1,000,000 unlisted options, exercisable at $0.0968 each, set to expire on 23 November 2024. The change, which involved no monetary transaction, was detailed in a formal notice to the ASX, as per the listing rules.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.